BACKGROUND/OBJECTIVES: This study explored interactions between dietary fat intake and the tumor necrosis factor-a gene (TNFA) -238 G4A polymorphism (rs361525) on adiposity and serum lipid concentrations in apparently healthy premenopausal black and white South African (SA) women. SUBJECTS/METHODS: Normal-weight (N ¼ 107) and obese (N ¼ 120) black, and normal-weight (N ¼ 89) and obese (N ¼ 62) white SA women underwent measurements of body composition, fasting lipids and dietary intake, and were genotyped for the -238 G4A polymorphism. RESULTS: Black women had a higher -238 GA genotype frequency than white women (Po0.001), but there were no differences between body mass index groups. Black women with the -238 A allele had a greater body fat % than those with the GG genotype (Po0.001). Further, in black women, with increasing polyunsaturated:saturated fat ratio and omega-6 (n-6):omega-3 (n-3) ratio, high-density lipoprotein-cholesterol (HDL-C) concentrations decreased, and total cholesterol (T-C):HDL-C ratio increased in those with the GA genotype but not the GG genotype. In addition, with increasing n-3 polyunsaturated fatty acid intake (percentage of total energy intake, %E), T-C:HDL-C ratio decreased in those with the GA genotype, but not in those with the GG genotype. In white SA women, with increasing eicosapentaenoic acid (%E) intake, low-density lipoprotein-cholesterol concentrations decreased in those with the GG genotype but not the GA genotype. CONCLUSIONS: The -238 G4A polymorphism was associated with body fatness in black women. Interactions between -238 G4A genotypes and dietary fat intake on serum lipids and adiposity differed depending on dietary fat intake, but those for serum lipids were not the same in black and white SA women.
INTRODUCTION
Studies from our laboratory, 1 and others [1] [2] [3] have shown that dietary fat intake modifies the relationship between the tumor necrosis factor-a gene (TNFA) -308 G4A polymorphism (rs1800629) and adiposity, and serum lipid concentrations. Common to all these studies was that the pro-inflammatory A allele of the functional TNFA-308 G4A polymorphism was associated with increased risk for obesity and dyslipidemia, and appeared to be more responsive to dietary fat intake.
Notably, our findings on the relationships between dietary fat intake, the TNFA -308 G4A genotypes, obesity and dyslipidemia differed between black and white South African (SA) women. 1, 4 Differences in these relationships may be explained, in part, by ethnic differences in the distribution of inflammatory gene polymorphisms and inflammatory gene expression, 5, 6 insulin sensitivity, 6 obesity risk, dietary fat and specific fatty acid intake, and serum lipid concentrations between black and white SA women. 1, 7 The functional -308 G4A polymorphism within the promoter region of the TNFA gene is in close proximity to the TNFA -238 G4A polymorphism (rs361525). Although a number of studies have investigated the TNFA -308 G4A polymorphism, only a few have reported on the TNFA -238 G4A polymorphism and obesity, 8, 9 and to our knowledge only one study has investigated the interaction between dietary fat intake and this polymorphism on adiposity and serum lipid concentrations. 2 However, there are no studies that have explored these associations in healthy populations of different ethnicity.
Therefore, the aim of this study was to explore whether the TNFA -238 G4A polymorphism is associated with adiposity and serum lipid concentrations, and whether these associations differ depending on dietary fat intake in apparently healthy premenopausal black and white SA women. 1, 4 Inclusion criteria included: no previous diagnosis or undergoing therapy for diabetes, hypertension, dyslipidemia, HIV or other metabolic diseases, and not currently pregnant or lactating. Only women were included because of the high prevalence of overweight and obesity seen in both black and white SA women, and because of the differences in serum lipids between black and white women, which was previously described. 7 Approval was obtained from the Human Research Ethics Committee of the Faculty of Health Sciences at the University of Cape Town, and written informed consent was obtained from all subjects before participation. The study was performed in accordance with the principles of the Declaration of Helsinki, International Conference on Harmonisation Good Clinical Practice.
MATERIALS AND METHODS Subjects
recruited in the greater Cape Town area, from 2004 to 2006, as described previously.
Measurements
Body composition. The methods used in this study have been described in detail previously. 1 In brief, basic anthropometric measurements, including weight, height and waist and hip circumferences were taken, and whole body composition was measured using dual-energy X-ray absorptiometry (Hologic Discovery-W, software version 12.1, Hologic Inc., Bedford, MA, USA). Abdominal visceral and subcutaneous adipose tissue areas were measured using computerized tomography (Toshiba Xpress Helical Scanner, Toshiba, Tokyo, Japan) at the level of L4-L5 lumbar vertebrae. 10 Blood sampling and analysis Blood samples were drawn from the antecubital vein after an overnight (10-12 h) fast, for the determination of serum triglyceride, total cholesterol (T-C), high-density lipoprotein-cholesterol (HDL-C) and low-density lipoprotein-cholesterol (LDL-C) concentrations, and for DNA extraction. Fasting plasma glucose concentrations were measured using the glucose oxidase method (Glucose Analyzer 2, Beckman Coulter, Inc. (Brea, CA, USA)) and serum insulin concentrations by a micro particle enzyme immunoassay (Abbott AxSym Insulin kit (North Chicago, IL, USA)). Serum triglyceride, T-C and HDL-C concentrations were measured on the Roche Modular Auto Analyzer (Roche Diagnostics, Mannheim, Germany) using enzymatic colorimetric assays. LDL-C was calculated using the Friedewald equation.
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Serum concentration of high-sensitivity C-reactive protein (hsCRP; Immun Diagnostik AG, Bensheim, Germany) was analyzed using a commercially available enzyme-linked immunosorbent assay kit according to the manufacturer's protocol. Persons with measurements of hsCRP greater than 10 mg/l were excluded from the analyses.
DNA extraction and genotype analysis. DNA was extracted using the method of Lahiri and Nurnberger. 12 Genotyping of the -238 G4A polymorphism (rs361525) within the proximal promoter of the TNFA gene was performed by PCR amplification and digested with the BamH1 restriction enzyme as previously described. 13 The G to A substitution eliminates a BamHI restriction site. The primers amplify a 165-bp fragment that is cut into 123-and 42-bp fragments with the G allele, but not with the A allele. The digestion fragments were resolved on 2% agarose gels and visualized under ultraviolet light. Repeat samples including controls were included in all experiments.
Dietary assessment. Dietary intake was estimated using a quantified food frequency questionnaire 14, 15 as previously described. 1 Nutrient intake was calculated by means of the software program FoodFinder, III (South African Medical Research Council, Cape Town, South Africa). 16 Underreporting and overreporting were detected on the basis of the ratio of energy intake (kJ per day):estimated resting metabolic rate (kJ per day, Harris Benedict equation 17, 18 ). Upper and lower cut-points were calculated assuming a sedentary lifestyle of 1.55 Â basal metabolic rate as defined by the physical activity level values from the WHO recommended energy requirements. 19 Participants were only included in the diet-gene analysis if this ratio was between 1.05 and 2.28. 17, 18 After applying these cut-off points, only 74 white and 72 black normal-weight, and 47 white and 70 black obese adequate reporters were included in the analysis. There were no differences between the over-and underreporters, and the adequate reporters for body composition or metabolic outcomes (results not shown).
Statistical analysis
In order to explore the metabolic effects of extreme ranges in BMI and, hence, most other measures of obesity and fat distribution while maintaining a unimodal distribution for lipid profile, we included only normal-weight and obese women. Genotype and allelic frequency distributions were tested for association with BMI groups and ethnicity using logistic regression (a generalized linear model with binomial family and logit link), adjusting for each other. Exact tests of Hardy-Weinberg equilibrium, as well as linkage disequilibrium (LD) with the TNFA -308 G4A polymorphism, were assessed for black and white women.
There was only one woman (black, normal-weight) with the TNFA -238 AA homozygous genotype. For all analyses, she was grouped with those with a GA genotype, assuming a dominant effect of the A allele, as done previously by other authors such as Fontaine-Bisson et al. 2, 20 The obese women were older than the normal-weight women and, therefore, all analyses were age-adjusted.
General linear models were used to model body composition and lipid variables as functions of BMI group and the TNFA -238 G4A polymorphism in black and white women separately, and together in the same model, including their interaction, while covarying for age. Outcomes were either left untransformed, or transformed (adding a constant, then taking the natural log) when required, to approximate normality, for analysis.
Dietary fats were the focus of the analysis because of their interaction with inflammation, obesity risk and serum lipids. [21] [22] [23] In adequate reporters only, we modeled dietary variables as a function of BMI and ethnic group adjusted for age. Using general linear models, we assessed adequate reporters in black and white women separately, to identify any associations between the TNFA -238 G4A polymorphism, and body composition and serum lipids, and the influence of dietary fat intake (so-called gene-environment interactions) on this relationship, adjusting for age. When we found interactions between dietary fatty acids and the TNFA -238 G4A polymorphism on body composition and serum lipids, we presented graphs to aid in their description and interpretation, because interaction effects, especially between transformed variables, are difficult to describe. In order to determine if the interaction effects were different between black and white women, we adjusted/covaried for ethnicity. A non-significant result would signify that the interaction effects were different in black and white women. This was confirmed by performing a three-way interaction between ethnic group, dietary fat intake (percentage of total energy intake, %E) and the TNFA -238 G4A polymorphism on body composition and serum lipid levels, adjusted for age and age and fat mass, respectively.
Results corresponding to P-values below 5% are described as significant. We did not adjust for multiple testing because it has been suggested that corrections, such as Bonferroni, are too conservative when several associations are tested in the same group of individuals, 24 and might not be appropriate in a situation such as this, where there is prior evidence that such effects exist. 25 Analyses were done in R, a language and environment for graphics and statistical computing, freely available from http://www.R-project.org. 26 The R package genetics was used for allele and genotype frequencies, HardyWeinberg equilibrium and LD probability testing.
RESULTS

Genotype distribution
The genotype and minor allele frequency distribution for lean and obese, black and white women are presented in Table 1 . There were no differences in genotype frequencies between BMI groups in black (P ¼ 0.178) or white women (P ¼ 0.533). However, the difference in genotype distribution between black and white women was highly significant after adjusting for BMI group (Po0.001); the A allele frequency was higher in black than in white women. The A allele frequency, particularly in the black women appears to be higher than that reported in the Ensemble data base (www.ensembl.org; Table 1 ). The normal-weight and obese white, and the normal-weight black groups were in HardyWeinberg equilibrium (P ¼ 0.600, P ¼ 1.00 and P ¼ 0.113, respectively), but the black obese group was not (Po0.001). As these were selected populations, this was not unexpected. The TNFA -238 G4A SNP was in tight LD with TNFA -308 G4A only in the normal-weight white women (D' ¼ 0.99).
Body composition and metabolic outcomes according to BMI, ethnicity and genotype Summaries of body composition and metabolic outcomes, separated by the genotypes for the TNFA -238 G4A polymorphism and BMI group are presented in Table 2 for black and in Table 3 for white women, with age-adjusted P-values comparing the outcomes between BMI groups and the genotypes for the TNFA -238 polymorphism. Supplementary Table S1 contains corresponding P-values for the combined sample after adjusting for ethnic group.
All body composition and metabolic outcomes, except hsCRP, differed between black and white women (Supplementary Table  S1 ). The white women had greater weight and waist than the black women, and the black women had higher BMI and body fat % than the white women. In addition, fasting glucose and all serum lipid concentrations were higher in the white compared with the black women (Supplementary Table S1 ).
As expected, all measures of body composition (except height) were different between the normal-weight and obese (Po0.001), in the black (Table 2 ), in white (Table 3 ) and in the combined groups (Supplementary Table S1) after adjusting for age. In the combined group, and separately in the black and white women, serum insulin concentrations and hsCRP concentrations were higher in obese versus normal-weight women (Po0.001; Tables 2 and 3, and  Supplementary Table S1 ). In white women, all measures of serum lipid concentrations were different between the BMI groups (Table 3) , but in black women only triglyceride, HDL-C and T-C:HDL-C ratio were different between the normal-weight and obese groups after adjusting for age (Table 2 ).
In the black women and combined group, those with the TNFA -238 A allele had a greater body fat % than the GG genotype group (Po0.001 (black) and P ¼ 0.004 (combined)) independent of age and BMI group (Table 2 and Supplementary Table S1 ). In black and white women, no other measures of adiposity or metabolic outcomes were different between the genotype groups (Tables 2 and 3 ).
Dietary intake Dietary intake of the normal-weight and obese black and white adequate reporters are summarized in Table 4 . The obese groups consumed more energy (kJ; Po0.001), total fat (P ¼ 0.023), saturated fatty acid (SFA; P ¼ 0.041), polyunsaturated fatty acid (PUFA; P ¼ 0.007), omega-6 (n-6) PUFA (P ¼ 0.010), linoleic acid (P ¼ 0.011), arachidonic acid (Po0.001), eicosapentaenoic acid (EPA; P ¼ 0.037) and docosahexaenoic acid (DHA; %E; P ¼ 0.043) than the normal-weight groups. The black women consumed more energy (kJ; Po0.001), carbohydrate (Po0.001), total fat (P ¼ 0.002), PUFA (Po0.001), n-6 PUFA (Po0.001), linoleic acid (Po0.001), arachidonic acid (Po0.001), EPA (Po0.001) and DHA (%E; P ¼ 0.001), as well as had higher polyunsaturated fat:saturated fat (Po0.001) and n-6:omega-3 (n-3) PUFA (Po0.001) ratios than the white women. In contrast, the white women consumed more protein (Po0.001), SFA (Po0.001) and a-linolenic acid (%E; Po0.001) compared with the black women.
Diet-genotype interactions on BMI and body composition In black women we detected interactions between dietary fat intake and the TNFA -238 G4A polymorphism on measures of adiposity (Supplementary Table S2 ). With increasing total fat and SFA intake (%E), weight (P ¼ 0.034 and P ¼ 0.017), waist (P ¼ 0.036 and P ¼ 0.012) and fat mass (P ¼ 0.047 for SFA only) increased for those with the GA genotype, but not the GG genotype. With increasing monounsaturated fat intake (%E) weight (P ¼ 0.044) increased for the GA genotype, but not the GG genotype, and with increasing a-linolenic acid intake (%) the rates of change in waist (P ¼ 0.007), BMI (P ¼ 0.012), body fat % (P ¼ 0.006), waist (P ¼ 0.044) and fat mass (P ¼ 0.005) also differed, but neither individual rate is significant. As an example, the interaction between SFA intake, the TNFA -238 G4A polymorphism and waist in black women is illustrated in Figure 1 .
No diet-genotype interactions with obesity or body composition were identified in the white women (Supplementary Table  S3 ), nor in the combined group after adjusting for ethnicity (Supplementary Table S4 ). However, the interaction between dietary intake and the TNFA -238 G4A polymorphism did not differ by ethnicity (Supplementary Table S5 ), suggesting that the association was not different between black and white women.
Diet-genotype interactions on serum lipids
In black women we detected interactions between dietary fat intake and the TNFA -238 G4A polymorphism on serum lipid levels (Supplementary Table S6 ). With increasing polyunsaturated fat:saturated fat ratio, HDL-C concentrations decreased in those with the GA (P ¼ 0.013) but not in the GG genotype, and as expected the T-C:HDL-C ratio increased in those with the GA genotype but not in the GG genotype (P ¼ 0.032). With increasing n-6:n-3 ratio, the rates of change in HDL-C concentration (P ¼ 0.032) and T-C:HDL-C ratio (P ¼ 0.004) differed between the GG and GA genotypes, but did not change significantly with either of the genotypes As an example, the interaction between n-6:n-3 ratio, the TNFA -238 G4A polymorphism, HDL-C and the T-C:HDL-C ratio is illustrated in Figure 2 . With increasing n-3 PUFA (P ¼ 0.012) intake (%E), the T-C:HDL-C ratio decreased in those with the GA, but not in those with the GG genotype (Supplementary Table S6) .
In white women, with increasing EPA (P ¼ 0.020)(%E) intake, LDL-C decreased in those with the GG genotype but not the GA genotype (Supplementary Table S7 ). Similarly, with increasing EPA (%E; P ¼ 0.041) and DHA (%E) intakes (P ¼ 0.040), T-C decreased in those with the GG genotype and not with the GA genotype, but the individual rates were not significant (Supplementary Table S7 ).
The ethnic-specific nature of these diet-genotype interactions were examined by including both black and white women in the same model and adjusting for ethnicity (Supplementary Table S8 ), as well as by examining the three-way interactions between the ethnic group, dietary fat intake (%E) and the TNFA -238 G4A polymorphism on serum lipid levels (Supplementary Table S9 ). We showed that the association between the n-6:n-3 ratio and the genotype on T-C:HDL-ratio was noted specifically in the black women (P ¼ 0.015, Supplementary Table S9), whereas the associations between EPA and DHA (%E), and genotype on LDL-C (P ¼ 0.004 and P ¼ 0.006, respectively) and T-C (P ¼ 0.019 and P ¼ 0.014, respectively) were specific to the white women (Supplementary Table S9 ).
DISCUSSION
The main findings of the study were that black women with the TNFA -238 GA genotype had a greater body fat % than those with the GG genotype, and that associations between the -238 G4A polymorphism and serum lipids differed depending on dietary fat intake; moreover, these associations differed in the black and white SA women.
Previous studies have found no association between the TNFA -238 G4A polymorphism and BMI. 8, 9 To our knowledge, this is the first study to report that the A allele of the TNFA -238 polymorphism is associated with a greater body fat % than the GG genotype. We demonstrated this effect in black women, as well as in the combined black and white group, independent of ethnicity. The pro-inflammatory A allele of the TNFA -308 G4A polymorphism has been independently associated with obesity risk in some, 27, 28 but not all previous studies. 29, 30 Obesity is associated with chronic subclinical systemic inflammation, characterized by increased production of pro-inflammatory cytokines, such as tumor necrosis factor-a (TNFa), released by adipose tissue. 31 There is, however, controversy regarding the functional significance of the TNFA -238 polymorphism. Studies have reported that the -238 A allele either increases, 32 decreases 33, 34 or has no effect on TNFA transcription, 35, 36 depending on the conditions of the experiment. Our findings suggest that the A allele of the -238 polymorphism may be responsive to dietary fatty acid intake, as has been shown for the -308 A allele. 1, 3, 27, 28, 37 However, understanding the inflammatory impact of this polymorphism needs to be confirmed. Measures of circulating TNFA or TNFA receptor levels may be informative in this respect. However, we found no genotype association with hsCRP levels, a marker of generalized inflammation. The hsCRP is known to be regulated only in part by TNFa and, therefore, may not be reflective of the inflammatory effects of TNFa, which acts predominately in a paracrine manner. 38, 39 Human studies have also shown that TNFa expression is regulated by dietary fatty acids, [40] [41] [42] and previous studies on the TNFA -308 G4A polymorphism have shown that the relationship between this polymorphism and obesity risk differed depending on dietary fat intake. 1, 3 In agreement with this, and to our best knowledge, we are the first to show that with increasing dietary fat intake, irrespective of the type and quality, select measures (weight, BMI, body fat %, fat mass and waist) of body composition increased in black women with the TNFA -238 GA genotype and decreased or did not change in those with the GG genotype ( Figure 1) .
In this study, we also showed that the relationship between the TNFA -238 G4A polymorphism and serum HDL-C concentration differed depending on the intake of specific PUFAs in black but not in white women (Figure 2) . Similarly, Fontaine-Bisson et al. reported that PUFA (%E) intake was positively associated with serum HDL-C concentrations in carriers of the -238 A allele within a mixed ethnicity, diabetic Canadian population. The effects of n-6 PUFAs on inflammation are contradictory and inconclusive. 43, 44 The n-6 PUFAs have, however, been shown to reduce LDL-C concentrations and T-C:HDL-C ratio, although some studies have also reported a decrease in HDL-C. 43, 45 In contrast, a high n-6:n-3 PUFA ratio is regarded as pro-inflammatory and has been associated with cardiovascular disease, inflammatory and autoimmune diseases. 44, [46] [47] [48] Notably, the intake of n-6 PUFAs (%E) and the n-6:n-3 PUFA ratio in the black women were higher than that of the white women in this study (8.3% versus 5.6%, and 26.4:1 versus 16.1:1, for black and white women, respectively) and that reported in other populations (4.0-6.0% for n-6 PUFA (%E), 43 and B15:1 for n-6:n-3 PUFA ratio 49 ). In this study, the interaction between the TNFA -238 G4A polymorphism and n-6:n-3 ratio on T-C:HDL-C ratio was only observed in the black women. These findings are relevant in this context as the black women in this study had lower HDL-C concentrations than the white women.
These findings need to be replicated in other African populations, as it has been shown that other African populations and African Americans have higher HDL-C concentrations than their white counterparts. [50] [51] [52] Despite higher HDL-C levels, white women in this study had a more atherogenic lipid profile than black women. 50, 53 We reported that the relationship between the TNFA -238 G4A polymorphism and serum LDL-C and T-C concentrations differed, depending on the intake of the n-3 PUFA's EPA and DHA, in white but not in black women. The intake of n-3 PUFA (%E) in this study was the same for the black and white women, but is approximately half of that previously reported in the Fontaine-Bisson study, which included a non-diabetic Canadian population. 54 These differences are relevant and worth exploring further, as n-3 PUFAs have been shown to attenuate inflammation, particularly EPA and DHA, which regulate inflammatory processes and have also been shown to improve serum lipid concentrations and vascular endothelial function. 55, 56 Dietary fatty acids affect inflammation and serum lipids in different ways; for this reason, the inclusion of individual fatty acids in diet-genotype studies is important. The differences in dietary fat intake, as well as differences in the association between insulin sensitivity and serum lipids 57 between black and white SA women, may explain the ethnic differences in these findings.
This study is novel and adds to the literature, as it is the first to highlight differences in the associations between the TNFA -238 G4A polymorphism, adiposity and serum lipid concentrations and their interaction with dietary fat intake in different ethnic groups. There are, however, limitations to this study that should be considered. Accuracy of diet reporting is always difficult. We aimed to improve the validity of the dietary intake data by using a validated food frequency questionnaire developed specifically for Metabolic outcomes/lipids and hsCRP: summarized as median (IQR). Outcomes were log-transformed for modeling. P-values are from age-adjusted linear models of the interaction between the BMI group and genotype on variable. P-values were calculated consecutively, from left to right, each adjusted for age and factors already tested.
the SA population, and by including only adequate reporters in the analyses. Other lifestyle factors, such as physical activity and socio-economic factors, may also interact with these variables, but were not included in this study. Our sample size was small, included no men and had fewer white than black women, which means that we could have failed to detect small associations in the white women, which we did detect in the black women.
Another possibility for the failure to show associations between the genotype and body composition in white women could be the difference in the A allele frequency between ethnic groups, which was lower in the white women. The frequencies in the white women were similar to those published in the literature (Table 1) ; however, the A allele frequency in the black women is higher than that reported. There are however no studies that have reported this genotype in the SA populations (as opposed to Sub-Saharan Africans, which refers to West Africans).
This study also investigated the -238 G4A and -308 G4A polymorphisms as a haplotype. Although these polymorphisms are only 69 bp apart (http://www.ensembl.org), they were only in LD in the white normal-weight population and not in the obese white group, nor the black groups. For these reasons, the haplotypes were not informative and were not reported here. It is not surprising that the two variants were not in LD in the black populations as rapid decay in LD have been shown to be more associated with populations from African descent compared with populations of non-African descent. 58 It is also not surprising to note the differences in the frequency distribution of the genotypes and alleles for these two variants within the various populations. This study therefore highlights why it is important to explore this particular genetic interval defined by these two variants in populations of African descent so that we can unravel the functional significance of TNFA in modulating an individuals' response to dietary fat intake.
In conclusion, we identified a novel association between the TNFA -238 G4A polymorphism and body fat %, as well as responsiveness of the -238 A allele to increasing dietary fat intake for adiposity in black SA women. We also showed that the relationship between the TNFA -238 G4A polymorphism and serum lipids differed, depending on PUFA intake, in both black and white SA women, but that these interactions were ethnic-specific. Although the results of this study provides new insight into the TNFA -238 G4A polymorphism, they also highlight the need for further research to study the TNFA −238 genotype GG GA Figure 1 . The relationship between adiposity, TNFA -238 G4A genotype and dietary saturated fat intake in normal-weight and obese black adequate reporter women. Symbols represent, for each woman, observed values. The lines are modeled relationships for a woman of average age (27.3 years). With increasing saturated fat intake (%E), adiposity increased for the A allele, whereas the GG genotype did not. Abbreviations: BMI, body mass index; %E, percentage of total energy intake; IQR, interquartile range; CHO, carbohydrate; SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid; P:S ratio, polyunsaturated fat:saturated fat ratio; n-3 PUFA, omega-3 PUFA; n-6 PUFA, omega-6 PUFA; ALA, a-linolenic acid; LA, linoleic acid; AA, arachidonic acid; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid. Dietary intake includes adequate reporters only. Summarized as median (IQR). Outcomes were log-transformed when required for modeling. P-values are from age-adjusted linear models of outcomes, testing the difference between BMI and ethnic groups each adjusted for the other.
functional significance of this polymorphism in both men and women of different ethnic origin.
CONFLICT OF INTEREST
Yael Joffe is a consultant to a South African genetics company, DNAlysis Biotechnology. She is also co-author of the book 'It's not just your genes!', she receives no profits or royalties from this book. All other authors declare no conflict of interest. The relationship between serum lipids, TNFA -238 G4A genotype and n-6:n-3 ratio in normal-weight and obese black adequate reporter women. Symbols represent, for each woman, observed values. The curves on each graph are from general linear models of age, fat mass and the interaction between TNFA -238 G4A genotype and specific dietary fat intake for a woman aged 27.3 years with fat mass 29.4 kg. With increasing n-6:n-3 ratio, HDL-C concentrations increased in those with the GG genotype and decreased in those with the GA genotype (a). In contrast, with increasing n-6:n-3 ratio, the T-C:HDL-C ratio increased in those with the GA genotype and decreased in those with the GG genotype (b).
